Biological and targeted-synthetic disease-modifying anti-rheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: real-life TReasure prospective data


Kimyon G., Kalyoncu U., Kiraz S., Bes C., COŞKUN N., Yagiz B., ...More

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, vol.39, no.4, pp.852-858, 2021 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Article
  • Volume: 39 Issue: 4
  • Publication Date: 2021
  • Title of Journal : CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
  • Page Numbers: pp.852-858
  • Keywords: leflunomide, methotrexate, rheumatoid arthritis, biologic or targeted-synthetic DMARDs, COMBINATION, THERAPY, MANAGEMENT, MONOTHERAPY

Abstract

Objective